ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

SOPH Sophia Genetics SA

4.64
0.09 (1.98%)
21 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Sophia Genetics SA NASDAQ:SOPH NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.09 1.98% 4.64 4.10 4.94 4.75 4.52 4.60 21,066 22:26:26

SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full-Year 2023 on March 5, 2024

20/02/2024 3:46pm

GlobeNewswire Inc.


Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart


From Nov 2023 to May 2024

Click Here for more Sophia Genetics Charts.

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the fourth quarter and full-year 2023 before U.S. markets open on Tuesday, March 5, 2024. On that day, SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:00 a.m. (08:00) EDT / 2:00 p.m. (14:00) CET.

The call will be webcast live on the SOPHiA GENETICS Investor Relations website. Additionally, a replay will be available on the website after its completion.

About SOPHiA GENETICS

SOPHiA GENETICS (Nasdaq: SOPH) is a software company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-native platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products, and services are currently used by a broad network of hospital, laboratory, and biopharma institutions globally. For more information, visit SOPHiAGENETICS.COM, or connect on X, LinkedIn, Facebook, and Instagram. Where others see data, we see answers.

Investor Contact
Kellen Sanger
IR@sophiagenetics.com

Media Contact
Kelly Katapodis
media@sophiagenetics.com

1 Year Sophia Genetics Chart

1 Year Sophia Genetics Chart

1 Month Sophia Genetics Chart

1 Month Sophia Genetics Chart

Your Recent History

Delayed Upgrade Clock